Literature DB >> 8197130

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.

D C Bicknell1, A Rowan, W F Bodmer.   

Abstract

The technique of single-strand conformation polymorphism (SSCP) was used to screen a series of 37 established colorectal cell lines, 22 fresh tumor samples, and 22 normal DNA samples for mutations in the beta 2-microglobulin gene. Exon 1 (including the leader peptide sequence) and exon 2 were screened separately. Six of 37 colorectal cell lines and 1 of 22 fresh tumors were shown to contain mutations, whereas no mutations were detected in the normal DNA samples. Sequencing of these mutations showed that an 8-bp CT repeat in the leader peptide sequence was particularly variable, since 3 of the cell lines and one fresh tumor sample have deletions in this region. In the related cell lines, DLD-1 and HCT-15, two similar mutations were identified, a C-->A substitution in codon 10 and a G-->T mutation in the splice sequence of intron 1. Expression of beta 2-microglobulin was examined using a series of monoclonal antibodies in an ELISA system. Reduced expression correlated with a mutation in one allele of beta 2-microglobulin, whereas loss of expression was seen in instances where a line was homozygous for a mutation or heterozygous for two mutations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197130      PMCID: PMC43866          DOI: 10.1073/pnas.91.11.4751

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Solid phase in vitro mutagenesis using plasmid DNA template.

Authors:  T Hultman; M Murby; S Ståhl; E Hornes; M Uhlén
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

4.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

5.  Characterization of 4AOHW cell line panel including new data for the 10IHW panel.

Authors:  M A Degli-Esposti; M S Griffiths; L N Daly; C S Witt; M Simons; C Carcassi; E D Albert; M J Giphart; R L Dawkins
Journal:  Hum Immunol       Date:  1993-09       Impact factor: 2.850

6.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

7.  Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.

Authors:  C M D'Urso; Z G Wang; Y Cao; R Tatake; R A Zeff; S Ferrone
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation.

Authors:  D Shibata; M A Peinado; Y Ionov; S Malkhosyan; M Perucho
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

9.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

10.  The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon.

Authors:  F Rosa; H Berissi; J Weissenbach; L Maroteaux; M Fellous; M Revel
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  31 in total

Review 1.  The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

Authors:  R S Blumberg; Y van de Wal; S Claypool; N Corazza; B Dickinson; E Nieuwenhuis; R Pitman; G Spiekermann; X Zhu; S Colgan; W I Lencer
Journal:  Acta Odontol Scand       Date:  2001-06       Impact factor: 2.331

2.  Alternative genetic pathways in colorectal carcinogenesis.

Authors:  S Olschwang; R Hamelin; P Laurent-Puig; B Thuille; Y De Rycke; Y J Li; F Muzeau; J Girodet; R J Salmon; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.

Authors:  Timothy T Spear; Timothy P Riley; Gretchen E Lyons; Glenda G Callender; Jeffrey J Roszkowski; Yuan Wang; Patricia E Simms; Gina M Scurti; Kendra C Foley; David C Murray; Lance M Hellman; Rachel H McMahan; Makio Iwashima; Elizabeth Garrett-Mayer; Hugo R Rosen; Brian M Baker; Michael I Nishimura
Journal:  J Leukoc Biol       Date:  2016-02-26       Impact factor: 4.962

4.  Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.

Authors:  M Wang; P W Chen; V Bronte; S A Rosenberg; N P Restifo
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1995-10

5.  Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.

Authors:  Amira A Barkal; Kipp Weiskopf; Kevin S Kao; Sydney R Gordon; Benyamin Rosental; Ying Y Yiu; Benson M George; Maxim Markovic; Nan G Ring; Jonathan M Tsai; Kelly M McKenna; Po Yi Ho; Robin Z Cheng; James Y Chen; Layla J Barkal; Aaron M Ring; Irving L Weissman; Roy L Maute
Journal:  Nat Immunol       Date:  2017-11-27       Impact factor: 25.606

Review 6.  The colorectal cancer immune microenvironment and approach to immunotherapies.

Authors:  Minoru Koi; John M Carethers
Journal:  Future Oncol       Date:  2017-08-22       Impact factor: 3.404

7.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

8.  Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.

Authors:  Chien-Chung Chang; Michael Campoli; Nicholas P Restifo; Xinhui Wang; Soldano Ferrone
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 9.  Strategies to genetically engineer T cells for cancer immunotherapy.

Authors:  Timothy T Spear; Kaoru Nagato; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2016-05-02       Impact factor: 6.968

10.  A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype.

Authors:  G Aquilina; P Hess; P Branch; C MacGeoch; I Casciano; P Karran; M Bignami
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.